Dentist or doctor visits can overwhelm autistic children with sensory sensitivities. Occupational therapy can help, Stein Duker says.

This month’s newsletter looks at the early safety data from the first gene therapy trial for Rett syndrome, among other drug development news.

The gene-editing advances make it easier to target specific tissues in mice and detect off-target effects.

The drugs may reopen a critical window during development in which the brain can more easily adjust its connections.

The results lend support for clinical trials of arbaclofen in people with an autism-linked condition, the researchers say.

Minimally verbal autistic preschoolers gained new words and phrases in a head-to-head comparison of two interventions.

In this episode of “Synaptic,” Kasari talks about the need for inclusion in educating autistic children, what drew her into the autism research field, and growing up on the family farm.

Changes to the DSM-5’s diagnostic criteria for autism were meant to add clarity, but they also generated new questions.

This month’s issue of Going on Trial takes a sneak peek at some early null results from a small trial of a cannabidiol-based drug for autism, among other recent drug developments.

A careful clinician who prizes evidence, Jeremy Veenstra-VanderWeele is happy to embrace trial failures, as long as he learns from them.